PASC Post Acute Sequelae of COVID 19: Clinical Trials

9 trials for PASC Post Acute Sequelae of COVID 19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 2 completed, 2 not yet recruiting, 1 active not recruiting. 4 Not applicable, 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Recruiting 3, Completed 1
Phase 23Completed 1, Not yet recruiting 1, Recruiting 1
Phase 11Not yet recruiting 1

Follow PASC Post Acute Sequelae of COVID 19: new trials by email Literature Review of PASC Post Acute Sequelae of COVID 19 trials Research Report on PASC Post Acute Sequelae of COVID 19

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Taurine Supplementation in Adolescents With Post-COVID Condition
Taurine - Long COVID, Post COVID-19 Condition
Phase 1 / Phase 2Not yet recruitingUniversity of Alberta302026-12-302026-10-16
Brain Stimulation in Long COVID
Repetitive Transcranial Magnetic Stimulation, Sham device - Long COVID, PASC Post Acute Sequelae of COVID 19
Not applicableRecruitingAmsterdam UMC, location VUmc662025-11-172025-12-19
Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
Physical Fatigue - PASC Post Acute Sequelae of COVID 19, Fatigue
Not applicableRecruitingHugo W. Moser Research Institute at Kennedy Krieger, Inc.2002025-07-162025-12-12
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
accelerated intermittent theta burst stimulation - Long COVID, Long COVID Syndrome
Phase 2RecruitingUniversity of New Mexico602025-07-072026-07-15
From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19
PASC Post Acute Sequelae of COVID 19, Long COVID
Not yet recruitingUniversity Medical Center Groningen602025-05-012025-04-04
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
rTMS - Long Covid-19, PASC Post Acute Sequelae of COVID 19
Not applicableCompletedUniversity of California, Los Angeles102025-01-012026-07-06
Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19
QI-GONG and control - PASC Post Acute Sequelae of COVID 19
Not applicableRecruitingPOCHIWU802024-12-022025-03-17
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Valacyclovir celecoxib dose 1, Valacyclovir celecoxib dose 2, Placebo - Long COVID, PASC Post Acute Sequelae of COVID 19
Phase 2CompletedBateman Horne Center592023-10-152025-01-22
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
AROMHA Longitudinal Smell Test - Anosmia, Asymptomatic COVID-19
Active not recruitingMassachusetts General Hospital10002022-11-142026-03-06

Narrower conditions

Post-Acute COVID-19 Syndrome (9)  ·  Fatigue (2)  ·  Anosmia (1)  ·  Influenza, Human (1)  ·  Mental Fatigue (1)

Broader conditions

COVID-19 (9)  ·  Chronic Disease (9)  ·  Coronaviridae Infections (9)  ·  Coronavirus Infections (9)  ·  Disease Attributes (9)  ·  Infections (9)  ·  Lung Diseases (9)  ·  Nidovirales Infections (9)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Pneumonia (9)  ·  Pneumonia, Viral (9)  ·  Post-Infectious Disorders (9)  ·  RNA Virus Infections (9)  ·  Respiratory Tract Diseases (9)

Interventions

Transcranial Magnetic Stimulation (2)  ·  DMAC2L protein, human (1)  ·  Qigong (1)  ·  Taurine (1)

Sponsors

Amsterdam UMC, location VUmc (1)  ·  Bateman Horne Center (1)  ·  Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1)  ·  Massachusetts General Hospital (1)  ·  POCHIWU (1)  ·  University Medical Center Groningen (1)  ·  University of Alberta (1)  ·  University of California, Los Angeles (1)  ·  University of New Mexico (1)

Countries

United States (5)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

Davin Quinn, MD (1)  ·  Helen Lavretsky, MD (1)  ·  J Pillay, MD PhD (1)  ·  Lawrence Richer, MD, MSc (1)  ·  Lucinda Bateman, MD (1)  ·  Mark W Albers, MD PhD (1)  ·  Mei-Hua Wang (1)  ·  Sander C.J. Verfaillie, Dr. (1)  ·  Vikram Chib, PhD (1)

NIH funding

R01NS140610 (1), U01DC019579 (1)